ML
CRBP icon

McAdam LLC’s Corbus Pharmaceuticals CRBP Stock Holding History

McAdam LLC’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-334
Closed -$6K – 264
2022
Q4 		$6K Hold
334
– – ﹤0.01% 194
2022
Q3 		$2K Hold
334
– – ﹤0.01% 217
2022
Q2 		$3K Hold
334
– – ﹤0.01% 220
2022
Q1 		$5K Hold
334
– – ﹤0.01% 213
2021
Q4 		$6K Hold
334
– – ﹤0.01% 194
2021
Q3 		$10K Hold
334
– – ﹤0.01% 179
2021
Q2 		$14K Buy
+334
New +$18.5K ﹤0.01% 176
2018
Q2 		– Sell
-3
Closed -$1K – 666
2018
Q1 		$1K Buy
+3
New +$674 ﹤0.01% 619

Other funds holding CRBP

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return